Format

Send to

Choose Destination
Swiss Med Wkly. 2012 Jul 16;142:w13622. doi: 10.4414/smw.2012.13622. eCollection 2012.

Stem cells for heart valve regeneration.

Author information

1
Swiss Centre for Regenerative Medicine, University of Zurich, Switzerland. benedikt.weber@access.uzh.ch

Abstract

Heart valve tissue engineering holds the potential to overcome limitations of currently used heart valve prostheses. It involves the isolation and expansion of autologous patient cells, the subsequent seeding of these cells onto an appropriate scaffold material, the in vitro incubation and the in vivo implantation of the derived tissue-engineered construct into the patient from whom the cells were taken. While vascular-derived cells require harvest of intact donor tissue and show limited expansion capacities, the use of stem or progenitor cells may overcome these limitations and expand the versatility of the concept of heart valve tissue engineering. Possible sources include cells isolated from blood, bone marrow, adipose tissue, amniotic fluid, chorionic villi, umbilical cord and induced pluripotent stem cells. Here we review different stem cell sources with particular regard to cellular phenotypes and their suitability for application in heart valve tissue engineering.

PMID:
22802212
DOI:
10.4414/smw.2012.13622
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for EMH Swiss Medical Publishers Ltd.
Loading ...
Support Center